Skip to search formSkip to main contentSkip to account menu

autologous tumor cell vaccine

Known as: AC vaccine, ATCV, Autologous Cell Vaccine 
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the… 
National Institutes of Health

Related topics

Related topics

2 relations
NCIt Antineoplastic Agent Terminologyautologous tumor cell vaccine/CD40-ligand/interleukin-2 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Colony stimulating factors secreted by irradiated autologous tumor cell vaccines inhibit immunity
Meeting abstracts Autologous tumor cell-based vaccines (ATCVs) have a number of potential advantages including multivalency and… 
Review
2015
Review
2015
Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
BackgroundCombination chemotherapy with mitomycin C and methotrexate (MM) was reported to be effective for 24% of patients with… 
2005
2005
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine
SummaryActive specific immunotherapy was performed in a phase I study in 20 colorectal cancer patients after surgical resection… 
Review
2003
Review
2003
Allogeneic breast cancer cell vaccines.
Cancer vaccines are currently a major focus of immunotherapy research. The combination of specific targeting and low levels of… 
2002
2002
Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell…
A phase I clinical trial using autologous, IL-7 gene-modified tumor cells in patients with disseminated melanoma has been… 
1998
1998
Bispecific antibodies increase T-cell stimulatory capacity in vitro of human autologous virus-modified tumor vaccine.
The production and functional testing of two new bispecific (bs) hybrid antibodies [Abs; bs Ab hemagglutinin-neuraminidase (HN) x… 
1998
1998
Early failure of an autologous pericardium aortic heart valve (ATCV) prosthesis.
BACKGROUND AND AIMS OF THE STUDY The risk of reoperation due to calcific degeneration is the most important drawback of… 
1988
1988
Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer.
Eighteen postoperative patients with non-small cell lung cancer were actively immunized with a vaccine that included autologous… 
1988
1988
Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
We studied the pharmacokinetic properties of two human monoclonal antibodies to colon carcinoma cells and their ability to detect… 
1979
1979
Preparation of autologous tumor cell vaccine from human lung cancer.
data1 wtCg)YieldViability C%)Culture.Subcutaneousdonetasismetas 2.4x1o@98Notoflungcancer2.Lungo@ 90Sterile7.Primarylungcancer0… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)